As of 2025-07-14, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 48.33 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -73.5%.
The range of the Relative Valuation is 30.01 - 67.36 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 21.9x | 18.3x |
| Forward P/E multiples | 11.6x - 21.6x | 15.6x |
| Fair Price | 30.01 - 67.36 | 48.33 |
| Upside | -83.6% - -63.1% | -73.5% |
| Date | P/E |